SARS-CoV-2 Spike Protein-Induced Interleukin 6 Signaling Is Blocked by a Plant-Produced Anti-Interleukin 6 Receptor Monoclonal Antibody
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the current COVID-19 pandemic, has caused more than 4.5 million deaths worldwide. Severe and fatal cases of COVID-19 are often associated with increased proinflammatory cytokine levels including interleukin 6 (IL-6)...
Guardado en:
Autores principales: | Collin Jugler, Haiyan Sun, Qiang Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0b310806add44e0da40974ac5a69bd0b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Association between interleukin-6/6R gene polymorphisms and coronary artery disease in Russian population: influence of interleukin-6/6R gene polymorphisms on inflammatory markers
por: Mitrokhin V, et al.
Publicado: (2017) -
Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications
por: Jamal Majidpoor, et al.
Publicado: (2022) -
Interleukin-6 (IL-6), Interleukin-8 (IL-8), and Tumor Necrosis FactorAlpha (TNF-a): Their Role in the Development and Metastasis of Tumor Cells
por: I Gede Angga Adnyana
Publicado: (2019) -
Interleukin-6: evolving role in the management of neuropathic pain in neuroimmunological disorders
por: Kenichi Serizawa, et al.
Publicado: (2021) -
Comparison of Interleukin-6 Plasma Concentration in Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Pediatric Sepsis
por: Franco Diaz, et al.
Publicado: (2021)